Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Immune checkpoint inhibitors: shaping the future of lymphoma

Stephen Ansell, MD, PhD, from the Mayo Clinic, Rochester, MN, USA, briefly describes the effectiveness and recent approval of immune checkpoint therapies in treating lymphoma for patients in the US and in Europe, noting that this new form of therapy will be accessible to patients in the distant future. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.